261 related articles for article (PubMed ID: 9369911)
1. [Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Masuda N
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():379-83. PubMed ID: 9369911
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy for advanced non-small cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 2005 Jun; 32(6):770-6. PubMed ID: 15984514
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
5. [Developed new agents for lung cancer].
Kato Y; Saijo N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
[TBL] [Abstract][Full Text] [Related]
6. [Non-cisplatin based chemotherapy in advanced non-small cell lung cancer].
Hosomi Y; Shibuya M
Gan To Kagaku Ryoho; 2007 Apr; 34(4):527-32. PubMed ID: 17431336
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Calvo AR; Belani CP
Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
[No Abstract] [Full Text] [Related]
8. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation in locally advanced non-small cell lung cancer.
Bonomi P; Shirazi W
Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
[No Abstract] [Full Text] [Related]
11. Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer.
Rosati G; Rossi A; Nicolella G; Panza N
Anticancer Res; 2000; 20(3B):2229-33. PubMed ID: 10928183
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
Ohe Y; Ohashi Y; Kubota K; Tamura T; Nakagawa K; Negoro S; Nishiwaki Y; Saijo N; Ariyoshi Y; Fukuoka M
Ann Oncol; 2007 Feb; 18(2):317-23. PubMed ID: 17079694
[TBL] [Abstract][Full Text] [Related]
13. Long-term survivors after chemotherapy in advanced non-small cell lung cancer.
Satoh H; Ishikawa H; Ohara G; Kagohashi K; Kurishima K; Ohtsuka M; Hizawa N
Anticancer Res; 2007; 27(6C):4457-60. PubMed ID: 18214060
[TBL] [Abstract][Full Text] [Related]
14. [Current perspectives of new agents in lung cancer].
Fukuoka M
Nihon Rinsho; 2000 May; 58(5):1103-10. PubMed ID: 10824557
[TBL] [Abstract][Full Text] [Related]
15. Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trials.
Frasci G; Panza N; Comella G; Pacilio G
Oncologist; 1999; 4(5):379-85. PubMed ID: 10551554
[TBL] [Abstract][Full Text] [Related]
16. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
17. A landmark point analysis with cytotoxic agents for advanced NSCLC.
Yamamoto N; Nambu Y; Fujimoto T; Koshiji M
J Thorac Oncol; 2009 Jun; 4(6):697-701. PubMed ID: 19318995
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the chemotherapy of non-small cell lung cancer.
Inoue A; Saijo N
Jpn J Clin Oncol; 2001 Jul; 31(7):299-304. PubMed ID: 11518741
[TBL] [Abstract][Full Text] [Related]
19. Two- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer.
Pirker R
Lung Cancer; 2002 Dec; 38 Suppl 3():S53-5. PubMed ID: 12468147
[TBL] [Abstract][Full Text] [Related]
20. A brief historical review of the development of chemotherapy for the treatment of advanced non-small cell lung cancer: why we should look beyond platinum.
Bengtson EM; Rigas JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):1-6. PubMed ID: 10585002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
